Comparative tumor analysis of CCL18 expression in GEPIA 2 (GEPIA 2) demonstrated significantly elevated expression levels in DLBCL relative to other malignant tumor types (Supplementary Figure 4A). Here, CCL18 is linked to diffuse large B-cell lymphoma.